Patients with ITP show significantly elevated mRNA expression of Bcl-6 and c-Maf transcription factors compared to healthy individuals, along with expansion in Tfh cells, whereas the mRNA level of c-Maf is notably reduced after treatment (99, 100). Here, BCL6 is linked to autoimmune thrombocytopenic purpura.